为探究静脉注射免疫球蛋白（IVIG）在皮肤科患者中引发血栓栓塞的频率，以及持续治疗对肾功能的影响，研究人员开展回顾性研究。结果显示，IVIG 治疗后，多次用药患者肾功能有差异，5 例（10.4%）eGFR 下降≥20%，5 例（10.4%）发生血栓栓塞。这为临床合理用药 ...

A new form of tumor infiltrating lymphocyte (TIL) therapy, a form of personalized cancer immunotherapy, dramatically improved the treatment's effectiveness in patients with metastatic gastrointestinal ...

Intravenous immunoglobulin (IVIG) is one treatment option. Crohn’s disease is a type of inflammatory bowel disease (IBD) that affects an estimated a million people in the United States.

Notably, we observed very low levels of TNF-α, and no IL-4 increase. IVIG treatment induced a significant reduction of IL-2 at day 14, IFN-γ at day 7, IL-15 at day 14 and a dramatic reduction of ...

In conclusion, we consider that the available data indicate that IVIg is not a lost cause for the therapy of MS 15,16, and that clinical trials are therefore warranted to determine if a ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Takeda Canada Inc. (Takeda) is pleased to announce that Health Canada has expanded the marketing authorization for HyQvia® ...

Given the predominance of IgG in IVIg products, it would have been prudent ... will help prevent unnecessary anxiety, antiviral therapy and the withholding of essential immunosuppressive agents.